Company Filing History:
1 out of 2 
1 out of 1,327 
1 out of 1 Years Active: 2024
Title: An Overview of Inventor Sarah Alice Long
Introduction
Sarah Alice Long, an innovative inventor based in Seattle, WA, has made significant contributions to the field of medical research, specifically in the prevention of type 1 diabetes (T1D). With one patent to her name, Long's work exemplifies a commitment to groundbreaking methodologies that address health challenges.
Latest Patents
Long's patent titled "Methods and compositions for preventing type 1 diabetes" outlines a crucial method for delaying the onset of clinical T1D. The method involves identifying a non-diabetic subject at risk for T1D and administering an effective amount of an anti-CD3 antibody. The innovation emphasizes the importance of monitoring specific T-cell populations, ensuring that subjects have a higher percentage of TIGIT+KLRG1+CD8+ T-cells, indicating a successful prevention strategy.
Career Highlights
Throughout her career, Sarah Alice Long has made impactful advancements within the field of diabetes research. She has developed her expertise in immunology and has been recognized for her contributions to understanding T1D. Her work not only contributes to scientific knowledge but also opens avenues for potential therapeutic interventions.
Collaborations
Long has collaborated with notable institutions, including Provention Bio, Inc. and Yale University. Her partnership with these organizations reflects her dedication to translating scientific research into practical applications. Additionally, she has worked closely with her colleague, Kevan C. Herold, enhancing the research efforts aimed at combatting diabetes.
Conclusion
Sarah Alice Long stands out as a pivotal figure in the field of medical innovation, particularly concerning type 1 diabetes. Her patent reflects a forward-thinking approach to health solutions, and her collaborations with significant organizations underline the importance of teamwork in driving research forward. As the fight against T1D continues, Long's contributions remain vital for future breakthroughs.